Bobylev, Dmitry
Horke, Alexander
Avsar, Murat
Cvitkovic, Tomislav
Boethig, Dietmar
Hazekamp, Mark
Meyns, Bart
Rega, Filip
Dave, Hitendu
Schmiady, Martin
Ciubotaru, Anatol
Cheptanaru, Eduard
Vida, Vladimiro
Padalino, Massimo
Tsang, Victor
Jashari, Ramadan
Laufer, Günther
Andreas, Martin
Andreeva, Alexandra
Tudorache, Igor
Cebotari, Serghei
Haverich, Axel
Sarikouch, Samir http://orcid.org/0000-0001-7277-7597
Funding for this research was provided by:
European Commission (No. 278453)
Medizinische Hochschule Hannover (MHH)
Article History
Received: 13 October 2022
Accepted: 23 February 2023
First Online: 14 March 2023
Declarations
:
: AH holds shares in corlife oHG, the company providing the service of processing decellularized allografts used in this study. RJ is Director of the European Homograft Bank. Martin Andreas has received institutional research funding (Edwards, Abbott, Medtronic, LSI), and has served as a proctor/speaker/consultant (Edwards, Abbott, Medtronic, Boston, Zoll). Guenther Laufer has received consulting fees from Edwards Lifesciences. All other authors declare that there are no conflicts of interest.